Latest News & Updates
Breaking News
19 hours ago
Simantini Singh Deo
Other trending news you may like to read
Tiziana Life Sciences Advances Alzheimer’s Program, Doses First Patient In Phase 2 Study
Tiziana begins Phase 2 dosing of intranasal foralumab, testing an immunomodulatory approach for early Alzheimer’s disease.
Simantini Singh Deo
Structure Therapeutics Begins Phase 1 Clinical Study Of Oral Small-Molecule Amylin Receptor Agonist ACCG-2671 For Obesity
Structure Therapeutics begins Phase 1 testing of ACCG-2671, an oral amylin receptor agonist designed to expand obesity treatment options.
Simantini Singh Deo
Processa Pharmaceuticals Reports Progress Update On Ongoing Phase 2 Trial In Metastatic Breast Cancer
Processa’s Phase 2 study shows NGC-Cap boosts active capecitabine metabolites while maintaining safety in advanced or metastatic breast cancer.
Simantini Singh Deo
Nuvectis Pharma Starts Phase 1b Study Testing NXP900 Plus Osimertinib In Non-Small Cell Lung Cancer
Nuvectis launches a Phase 1b study of NXP900 plus osimertinib to address resistance in EGFR-mutated non-small cell lung cancer.
Simantini Singh Deo
